Point72 Asset Management L.P. 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:19 pm Sale | 2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management L.P. | 1,178,501 1.900% | -1,828,637 (-60.81%) | Filing |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management L.P. | 3,007,138 5.800% | 365,885 (+13.85%) | Filing |
| 2021-10-28 5:24 pm Purchase | 2021-10-27 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management L.P. | 2,641,253 5.100% | 2,641,253 (New Position) | Filing |